{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:58:11Z","timestamp":1794484691274,"version":"4.9.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3627,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1038\/sj.ki.5000045","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T11:07:10Z","timestamp":1135249630000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":241,"title":["Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation"],"prefix":"10.1016","volume":"69","author":[{"given":"D.L.","family":"Andress","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.ki.5000045_bb0010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000045_bb0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0020","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/sj.ki.5000045_bb0030","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial medial calcification in end-stage renal disease: impact on all cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0035","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ndt\/gfh611","article-title":"Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic hemodialysis patients","volume":"20","author":"Yildiz","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10157-003-0260-0","article-title":"Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis","volume":"8","author":"Matsuoka","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0045","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","article-title":"Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality","volume":"103","author":"Wilson","year":"2001","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000045_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","article-title":"Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure","volume":"103","author":"Guerin","year":"2001","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000045_bb0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/jama.287.12.1548","article-title":"Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis","volume":"287","author":"Klassen","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/sj.ki.5000045_bb0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5000045_bb0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2004070610","article-title":"Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study","volume":"16","author":"Kramer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000045_bb0075","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1038\/sj.ki.5000045_bb0080","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"10.1038\/sj.ki.5000045_bb0095","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000045_bb0100","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcificaiton in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000045_bb0110","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1172\/JCI116391","article-title":"Bone morphogenetic protein expression in human atherosclerotic lesions","volume":"91","author":"Bostrom","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.RES.0000036607.05037.DA","article-title":"High-density lipoprotein regulates calcification of vascular cells","volume":"91","author":"Parhami","year":"2002","journal-title":"Circ Res"},{"key":"10.1038\/sj.ki.5000045_bb0120","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/01.ATV.18.12.1964","article-title":"Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory","volume":"18","author":"Watson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.ki.5000045_bb0125","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1074\/jbc.273.13.7547","article-title":"cAMP stimulates osteoblast-like differentiation for calcifying vascular cells. Potential signaling pathway for vascular calcification","volume":"273","author":"Tintut","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0130","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","article-title":"Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway","volume":"102","author":"Tintut","year":"2000","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000045_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","article-title":"Oxidative stress modulates osteoblastic differentiation of vascular and bone cells","volume":"31","author":"Mody","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/sj.ki.5000045_bb0140","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0145","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1093\/jn\/131.11.2910","article-title":"The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin-D-induced calcification of arteries, cartilage, lungs and kidneys in rats","volume":"131","author":"Price","year":"2001","journal-title":"J Nutr"},{"key":"10.1038\/sj.ki.5000045_bb0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20020911","article-title":"Inactivation of the osteopontin gene enhances vascular calcification of matrix gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo","volume":"196","author":"Speer","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/sj.ki.5000045_bb0155","doi-asserted-by":"crossref","first-page":"20197","DOI":"10.1074\/jbc.M909174199","article-title":"Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification","volume":"275","author":"Jono","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1538-7836.2003.00023.x","article-title":"Matrix gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats","volume":"1","author":"Sweatt","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1038\/sj.ki.5000045_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/03008208909049995","article-title":"Gla-containing proteins of bone","volume":"21","author":"Price","year":"1989","journal-title":"Connect Tissue Res"},{"key":"10.1038\/sj.ki.5000045_bb0170","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","article-title":"BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005344-200307000-00014","article-title":"Effects of adrenomedullin, C-type natriuretic peptide and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells","volume":"42","author":"Huang","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/sj.ki.5000045_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004410051353","article-title":"Expression of mRNAs for type I collagen, bone sialoprotein, osteocalcin and osteopontin at different stages of osteoblastic differentiation and their regulation by 1,25 dihydroxyvitamin D","volume":"297","author":"Bellows","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1038\/sj.ki.5000045_bb0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/excr.2002.5474","article-title":"1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2\/Cbfa1 gene promoter","volume":"274","author":"Drissi","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1038\/sj.ki.5000045_bb0190","first-page":"1237","article-title":"Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines","volume":"44","author":"Virdi","year":"1998","journal-title":"Cell Mol Biol"},{"key":"10.1038\/sj.ki.5000045_bb0195","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1046\/j.1523-1755.1998.00152.x","article-title":"Calcitriol modulates in vivo and in vitro cytokine production: a role of intracellular calcium","volume":"54","author":"Panichi","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0200","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0021-9258(19)35439-0","article-title":"1,25-dihydroxyvitamin D3 stimulates the synthesis of gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins in clonal osteoblastic cell lines","volume":"263","author":"Fraser","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0205","first-page":"E965","article-title":"1,25-dihydroxyvitamin D3 up-regulates natriuretic peptide receptor-C expression in mouse osteoblasts","volume":"275","author":"Yanaka","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000045_bb0210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention","volume":"8","author":"Li","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/sj.ki.5000045_bb0215","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.168.3.1181","article-title":"1,25-dihydroxyvitamin D inhibits IFN-\u03b3 and IL-4 levels during in vitro polarization of primary murine CD4+ T cells","volume":"168","author":"Staeva-Vieira","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/sj.ki.5000045_bb0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4+Tcells is induced by immunosuppressive drugs and inhibited by T helper type 1 (TH1)- and TH2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/sj.ki.5000045_bb0225","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1\u03b1,25-dihydroxyvitamin D3 has a direct effect on na\u00efve CD4+ T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/sj.ki.5000045_bb0230","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","volume":"279","author":"Aihara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0272-6386(12)80727-X","article-title":"Chronic renal failure is a state of cellular calcium toxicity","volume":"21","author":"Massry","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","article-title":"Effect of parathyroidectomy on left-ventricular function in haemodialysis patients","volume":"1","author":"Drueke","year":"1980","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000045_bb0245","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on the natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1038\/sj.ki.5000045_bb0255","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with pre-dialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0260","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","article-title":"Inactivation of the 25-hydroxyvitamin D 1 alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis","volume":"279","author":"Panda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0265","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1074\/jbc.M410720200","article-title":"Non-genotropic, anti-apoptotic signaling of 1\u03b1,25(OH)2-vitamin D and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3- and JNK kinases","volume":"280","author":"Vertino","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0270","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfg595","article-title":"Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure","volume":"19","author":"Rix","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0275","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.2003-030964","article-title":"Aortic calcification and the risk of osteoporosis and fractures","volume":"89","author":"Schulz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5000045_bb0280","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1755.2003.00837.x","article-title":"Total hip bone mass predicts survival in chronic hemodialysis patients","volume":"63","author":"Taal","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0285","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-dihydroxyvitamin D is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0290","first-page":"E124","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin\u2013angiotensin systems","volume":"228","author":"Xiang","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/sj.ki.5000045_bb0295","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-105-5-649","article-title":"Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism","volume":"105","author":"Resnick","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.ki.5000045_bb0300","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI118582","article-title":"1,25(OH)2 vitamin D3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes","volume":"97","author":"Wu","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0305","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1016\/S0021-9258(17)37635-4","article-title":"Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3","volume":"269","author":"Li","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5000045_bb0310","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.31.6.1338","article-title":"Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains","volume":"31","author":"Chen","year":"1998","journal-title":"Hypertension"},{"key":"10.1038\/sj.ki.5000045_bb0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0026-895X(25)08537-2","article-title":"Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxyvitamin D3","volume":"47","author":"Nambi","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1038\/sj.ki.5000045_bb0320","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/01.fjc.0000166212.04674.8b","article-title":"Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure","volume":"44","author":"Miyauchi","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/sj.ki.5000045_bb0325","doi-asserted-by":"crossref","first-page":"H22295","DOI":"10.1152\/ajpheart.00048.2004","article-title":"Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats","volume":"287","author":"Murray","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/sj.ki.5000045_bb0330","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1097\/01.fjc.0000166250.81733.a5","article-title":"Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin?","volume":"44","author":"Essalihi","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1038\/sj.ki.5000045_bb0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000013384","article-title":"Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis","volume":"18","author":"Lemilla","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0345","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate and severe renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5000045_bb0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ndt\/6.3.162","article-title":"Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism","volume":"6","author":"Reichel","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0355","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(97)90086-X","article-title":"Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure","volume":"30","author":"Kates","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0360","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0365","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1172\/JCI110586","article-title":"Metabolic acidosis suppresses 25-hydroxyvitamin D3-1alpha-hydroxylase in the rat kidney","volume":"70","author":"Kawashima","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0375","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.1991.287","article-title":"Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism","volume":"40","author":"Hsu","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0380","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ajcn\/76.1.187","article-title":"Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"76","author":"Nesby-O'Dell","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1038\/sj.ki.5000045_bb0385","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","article-title":"Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease, and osteoporosis","volume":"79","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1038\/sj.ki.5000045_bb0390","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease: a single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0395","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(80)90283-4","article-title":"Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol","volume":"2","author":"Papapoulos","year":"1980","journal-title":"Lancet"},{"key":"10.1038\/sj.ki.5000045_bb0400","first-page":"F746","article-title":"Kinetics of monocyte 1\u03b1-hydroxylase in renal failure","volume":"268","author":"Gallieni","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000045_bb0405","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2362.1998.00253.x","article-title":"Regulation of gp330\/megalin expression by vitamins A and D","volume":"28","author":"Liu","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0410","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"10.1038\/sj.ki.5000045_bb0415","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo.136.4.7895652","article-title":"The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands","volume":"136","author":"Brown","year":"1995","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000045_bb0420","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0425","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1073\/pnas.0501312102","article-title":"Parathyroid hormone decreases renal vitamin D receptor expression in vivo","volume":"102","author":"Healy","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5000045_bb0430","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21 WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5000045_bb0435","first-page":"iii9","article-title":"Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27","volume":"18","author":"Tokumoto","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0440","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0445","first-page":"F454","article-title":"Rat calcium-sensing receptor is regulated by vitamin D but not by calcium","volume":"270","author":"Brown","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000045_bb0450","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5000045_bb0455","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","article-title":"Parathyroid hyperplasia in uremic rats preceeds down-regulation of the calcium receptor","volume":"60","author":"Ritter","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0460","first-page":"F157","article-title":"Vitamin D","volume":"277","author":"Brown","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1038\/sj.ki.5000045_bb0465","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mlc.2002.122819","article-title":"Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport","volume":"139","author":"Brown","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1038\/sj.ki.5000045_bb0470","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jcb.10547","article-title":"Altered gene expression profile in the kidney of vitamin D receptor knockout mice","volume":"89","author":"Li","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1038\/sj.ki.5000045_bb0475","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1210\/endo-129-4-1876","article-title":"Non-genomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure\u2013function studies using ligand analogs","volume":"129","author":"Farach-Carson","year":"1991","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000045_bb0480","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1046\/j.1432-1033.2002.02915.x","article-title":"Non-genomic action of 1\u03b1, 25(OH)2vitaminD3. Activation of muscle cell PLC gamma through the tyrosine kinase c-Src and PtdIns 3-kinase","volume":"269","author":"Buitrago","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1038\/sj.ki.5000045_bb0485","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.0305802101","article-title":"Rapid modulation of osteoblast ion channel responses by 1\u03b1,25 (OH)2vitamin D3 requires the presence of a functional vitamin D nuclear receptor","volume":"101","author":"Zanello","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5000045_bb0490","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/endo.140.10.7025","article-title":"An insulinotropic effect of vitamin D analog with increasing intracellular calcium concentration in pancreatic beta cells through nongenomic signal transduction","volume":"140","author":"Kajikawa","year":"1999","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000045_bb0495","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1096\/fj.01-0584fje","article-title":"1\u03b1,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action","volume":"15","author":"Shi","year":"2001","journal-title":"FASEB J"},{"key":"10.1038\/sj.ki.5000045_bb0500","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1021\/bi00790a023","article-title":"Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine","volume":"10","author":"Holick","year":"1971","journal-title":"Biochemistry"},{"key":"10.1038\/sj.ki.5000045_bb0505","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jn\/114.11.2043","article-title":"Antirachitic activity of 1 alpha-hydroxyergocalciferol and 1 alpha-hydroxycholecalciferol in rats","volume":"114","author":"Sjoden","year":"1984","journal-title":"J Nutr"},{"key":"10.1038\/sj.ki.5000045_bb0510","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0515","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/endo.133.3.8396012","article-title":"The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine","volume":"133","author":"Brown","year":"1993","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5000045_bb0520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1, 25-(OH)2D3, 19-nor-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0525","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1523-1755.2002.kid573.x","article-title":"Differential effects of 19-nor-1,25-(OH)2D2 and 1 alpha-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats","volume":"62","author":"Slatopolsky","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0530","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-nor-1-alpha-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0535","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2001.22077","article-title":"Efficacy and side-effects of intermittent intravenous and oral doxercalciferol (1\u03b1-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: a sequential comparison","volume":"37","author":"Maung","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5000045_bb0540","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00111-2","article-title":"Clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0545","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archinte.1980.00330190042017","article-title":"Effects of long-term therapy with calcitriol in patients with moderate renal failure","volume":"140","author":"Healy","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1038\/sj.ki.5000045_bb0550","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0555","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5000045_bb0560","first-page":"733A","article-title":"Paricalcitol (Zemplar) capsule controls secondary hyperparathyroidism in chronic kidney disease stage 3 and 4 patients","volume":"15","author":"Coyne","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5000045_bb0565","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1,25-dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide","volume":"98","author":"Jono","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/sj.ki.5000045_bb0570","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1525-139X.2005.18407.x","article-title":"The role of vitamin D in vascular calcification in CKD","volume":"18","author":"Wolisi","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/sj.ki.5000045_bb0575","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Treat to Goal Working Group: Sevelamer attenuates the risk of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5000045_bb0580","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in hemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5000045_bb0585","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5000045_bb0590","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5000045_bb0595","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815513239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:48:03Z","timestamp":1758761283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815513239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0085253815513239"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5000045","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/sj.ki.5000045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}